Signalgene, Inc.
Source: SignalGene, Inc.
With our 10 years of experience, we have
invaluable expertise in genomics research. We have
developped a new, reliable and
cost-effective technological platform for high
throughput genotyping in a GLP-compliant
environment. When we began, our goal was to
offer this outstanding technology trouble-free and
affordably to those involved in the clinical
development of drugs.
We have achieved this goal!
YOU MAY ALSO LIKE...
-
Microfluidics Develops Methods For Processing Carbon Nanotubes
Microfluidics, a wholly owned subsidiary of MFIC Corporation, announced methods for processing bulk carbon nanotubes. Microfluidics has devised a methodology to process, deagglomerate, purify and... -
Hawk Measurement Introduces Smart Conductivity Level Switches
Hawk Measurement, a leading global provider of level, positioning and flow measurement technology, is introducing a new line of point level switches for conductive liquids. This type of switch is... -
GRANUMILL JR. Size Reduction Mill
GRANUMILL® JR. size reduction systems meet FDA SUPAC (Scale-Up and Post-Approval Changes) guidelines for both impact and screening mills, allowing for low-RPM screening of agglomerates in... -
BFB CP 38: High-Speed Side Loading Case Packer
The BFB CP 38 is a high speed side loading case-packer specifically designed to handle loose or bundled cartons. Servo technology and innovative solutions allow the machine to achieve a very high... -
Able Laboratories, Inc. To Sell Business In Light Of FDA Requirements
Able Laboratories, Inc. today announced a decision by its Board of Directors taken as the result of discussions it has been conducting with the FDA regarding its ongoing review of internal laboratory...
This website uses cookies to ensure you get the best experience on our website. Learn more